ALLMedicine™ Aortic Regurgitation Center

Sep 11th, 2021 - The aim of this study was to identify the optimal echocardiographic measurement of aortic regurgitation (AR) in continuous flow left ventricular assist devices (LVAD) and determine risk factors and clinical implications of de novo AR. Echocardiogr...

Sep 10th, 2021 - Different methods of aortic valve repair have been described in the literature for aortic regurgitation (AR) associated with doubly committed subarterial ventricular septal defects. Our goal was to present our experience with aortic valve reconstr...

Sep 7th, 2021 - Background Neo-aortic root dilation and neo-aortic regurgitation (AR) are common after arterial switch operation for D-loop transposition of the great arteries. We sought to evaluate these outcomes in patients with bicuspid native pulmonary valve ...

Sep 7th, 2021 - The main treatment for a ruptured sinus of Valsalva aneurysm (SVA) is surgical repair. Postoperative progression of aortic regurgitation (AR) following SVA repair increases the risk of reoperation, which decreases the long-term survival. Thus, ide...

Sep 3rd, 2021 - Echocardiographic evaluation of chronic aortic regurgitation (AR) severity can lead to diagnostic ambiguity due to few feasible parameters or incongruent findings. The aim of the present study was to improve the diagnostic usefulness of left ventr...

Jul 12th, 2021 - Patients with aortic stenosis, hypertrophic cardiomyopathy, mitral regurgitation, aortic regurgitation, artificial heart valve regurgitation or stenosis, and tricuspid valve regurgitation associated with pacemaker leads who are referred for clinic...

Jan 13th, 2021 - Transcatheter valve-in-valve replacement of a transcatheter aortic valve, so-called TAV-in-TAV, appears to offer procedural success that is better than, and procedural safety and mortality that are similar to, transcatheter valve-in-valve replacem...

Dec 29th, 2020 - The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a drug safety update highlighting a small risk of heart valve regurgitation with the use of systemic and inhaled fluoroquinolones. The update follows a European review of ep...

Nov 11th, 2020 - NEW YORK (Reuters Health) - In asymptomatic patients with chronic aortic regurgitation (AR), left ventricular end-systolic volume index (LVESVi) and volume-derived LV ejection fraction (Vol-LVEF) work as well as LV end-systolic dimension index (LV...

Oct 21st, 2020 - ACURATE neo's (Boston Scientific) place in the treatment of severe aortic stenosis is unclear after failing to show noninferiority in a head-to-head comparison with another self-expanding, supra-annular transcatheter valve and reporting lackluster...

Aug 3rd, 2020 - A new SWISS TAVI registry analysis provides some of the strongest evidence to date that the presence of left ventricular outflow tract (LVOT) calcification is a harbinger of worse outcomes in transcatheter aortic valve replacement (TAVR). Among 16...